Try our Advanced Search for more refined results

Gilead Sciences, Inc. v. Regents of the University of Minnesota

Track this case

Case Number:

Case Type:

IPR

Status:

Final Written Decision

Petitioner:

Gilead Sciences, Inc.

Patent Owner:

Regents of the University of Minnesota

Patent Number:

Tech Center:

1600

May 24, 2021
Gilead Gets PTAB To Wipe Out University's Antiviral IP Claims

The Patent Trial and Appeal Board has thrown out more than two dozen claims in a University of Minnesota patent covering a compound with antiviral and anti-cancer properties, handing a win to Gilead in a sprawling patent fight.
May 29, 2020
PTAB Takes Up 1 Of 2 Gilead Challenges To State Univ. Patent

Gilead nabbed a partial victory in its patent battle with the University of Minnesota when the Patent Trial and Appeal Board agreed to take up one challenge to the university's patent covering a compound with anti-viral and anti-cancer properties, but not another.
August 23, 2019
PTAB Puts U. Of Minn. Reviews On Ice For High Court Appeal

The Patent Trial and Appeal Board has agreed to put off a review of the University of Minnesota's patent on a hepatitis C treatment in light of the university's appeal of a recent Federal Circuit decision that state sovereign immunity doesn't apply in such reviews.